PHARMACEUTICAL INDUSTRY SYMPOSIUM 5 BY GENESIS
"New horizons in the treatment of Hematologic Malignancies"
Moderation: Prof. Marica Pavkovic
-Optimizing treatment options for patients with Relapsed/Refractory DLBCL- Dr Theodoros Vassilakopoulos (MD), Professor of Haematology, National and Kapodistrian University of Athens, Department of Hematology and Bone Marrow Transplantation, Laikon General Hospital, Athens, Greece
- CML treatment today - overcoming resistance to 2ND generation TKIs with ponatinib - 20 min, Prof. Marica Pavkovic, University Clinic for Hematology, Skopje, North Macedonia.